Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 54.40
+1.30 (2.45%)
Sep 17, 2026, 1:30 PM CST
Pell Bio-Med Technology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,852 | 306.7 | 427.37 | 167.68 | 172.4 | 115.78 |
Short-Term Investments | 316.31 | 351 | 479.75 | 938.15 | 536 | - |
Trading Asset Securities | - | - | 29.06 | - | - | - |
Cash & Short-Term Investments | 2,169 | 657.7 | 936.18 | 1,106 | 708.4 | 115.78 |
Cash Growth | 184.81% | -29.75% | -15.34% | 56.10% | 511.84% | - |
Accounts Receivable | 7.73 | 5.07 | 3.75 | 7.61 | 6.05 | 4.5 |
Other Receivables | 4.17 | 3.21 | 2.4 | 0.33 | 0.36 | 6.12 |
Receivables | 11.91 | 8.27 | 6.15 | 7.94 | 6.41 | 10.62 |
Inventory | 19.21 | 6.62 | 6.18 | 3.76 | 4.58 | 4.24 |
Prepaid Expenses | 38.44 | 5.46 | 9.22 | 8.86 | 5.84 | 1.1 |
Other Current Assets | 100.38 | 653.37 | 200 | 0.65 | 0.16 | 0.08 |
Total Current Assets | 2,339 | 1,331 | 1,158 | 1,127 | 725.39 | 131.82 |
Property, Plant & Equipment | 723.34 | 709.81 | 386.45 | 260.92 | 298.97 | 249.74 |
Long-Term Investments | 0.27 | 0.27 | 0.37 | 0.37 | 0.26 | 0.26 |
Other Intangible Assets | 20.24 | 2.93 | 1.89 | 2.4 | 2.71 | 1.47 |
Other Long-Term Assets | 73.02 | 67.8 | 198.39 | 27.44 | 17.07 | 10.61 |
Total Assets | 3,156 | 2,112 | 1,745 | 1,418 | 1,044 | 393.89 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 8.33 | 5.83 | 4.49 | 6.99 | 5.72 | 8.61 |
Accrued Expenses | 69.32 | 106.49 | 64.12 | 39.74 | 14.58 | 19.19 |
Short-Term Debt | 100 | 100 | 200 | - | 5 | - |
Current Portion of Leases | 30.13 | 27.99 | 27.55 | 25.09 | 25.07 | 10.76 |
Current Unearned Revenue | 0.01 | 0.02 | 0.02 | - | - | 0.75 |
Other Current Liabilities | 24.39 | 68.64 | 25.17 | 17.47 | 6.86 | 4.87 |
Total Current Liabilities | 232.19 | 308.97 | 321.35 | 89.3 | 57.24 | 44.18 |
Long-Term Leases | 101.39 | 109.28 | 137.27 | 147.47 | 172.56 | 124.84 |
Other Long-Term Liabilities | 0.02 | 0.02 | - | - | - | - |
Total Liabilities | 333.59 | 418.27 | 458.62 | 236.77 | 229.79 | 169.02 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 655.8 | 587.98 | 578.43 | 539.43 | 443.65 | 333.76 |
Additional Paid-In Capital | 3,713 | 1,910 | 1,804 | 1,449 | 774.25 | 77.38 |
Retained Earnings | -1,797 | -1,631 | -1,207 | -817.85 | -419.09 | -188.96 |
Treasury Stock | -0.6 | -0.8 | -0.8 | -0.8 | - | - |
Comprehensive Income & Other | 0.32 | 555.74 | 5.52 | - | 2.13 | 2.69 |
Total Common Equity | 2,572 | 1,422 | 1,180 | 1,170 | 800.94 | 224.86 |
Minority Interest | 249.94 | 272.07 | 106.29 | 11.18 | 13.67 | 0.01 |
Shareholders' Equity | 2,822 | 1,694 | 1,286 | 1,181 | 814.6 | 224.87 |
Total Liabilities & Equity | 3,156 | 2,112 | 1,745 | 1,418 | 1,044 | 393.89 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 231.52 | 237.27 | 364.82 | 172.56 | 202.63 | 135.6 |
Net Cash (Debt) | 1,937 | 420.43 | 571.36 | 933.27 | 505.77 | -19.82 |
Net Cash Growth | 372.06% | -26.41% | -38.78% | 84.52% | - | - |
Net Cash Per Share | 1.56 | 0.36 | 0.50 | 1.01 | 0.64 | -0.03 |
Filing Date Shares Outstanding | 1,310 | 1,174 | 1,156 | 1,078 | 887.3 | 665.54 |
Total Common Shares Outstanding | 1,310 | 1,174 | 1,156 | 1,078 | 887.3 | 665.54 |
Working Capital | 2,107 | 1,022 | 836.38 | 1,038 | 668.15 | 87.64 |
Book Value Per Share | 1.96 | 1.21 | 1.02 | 1.09 | 0.90 | 0.34 |
Tangible Book Value | 2,552 | 1,419 | 1,178 | 1,168 | 798.22 | 223.39 |
Tangible Book Value Per Share | 1.95 | 1.21 | 1.02 | 1.08 | 0.90 | 0.34 |
Machinery | 323.55 | 310.33 | 95.05 | 90.37 | 81.84 | 75.31 |
Construction In Progress | 315.71 | 285.99 | 148.34 | - | - | - |
Leasehold Improvements | 105.18 | 104.12 | 86.72 | 86.72 | 86.18 | 86 |